Make an Appointment
-
Chandan Krishna, MD6560 Fannin Street, Suite 944, Houston, TX 77030 map
-
Mayo Clinic Arizona13400 E Shea Boulevard, Scottsdale, Scottsdale, AZ 85259 map
Dr. Chandan Krishna is a neurosurgeon in Houston. He provides surgical treatments for a range of conditions affecting the nervous system, such as epilepsy and Parkinson's disease.
Chandan Krishna, MD
Accepting New Patients?
Yes, Dr. Chandan Krishna is accepting new patients at this office.
Phone
Fax
(713) 793-1001
Address
6560 Fannin Street, Suite 944, Houston, TX 77030
Office Details
Mayo Clinic Arizona
Please Note: This link will direct you to a third-party website unaffiliated with MD.com (http://www.mayoclinic.org/appointments), where you're able to request or schedule an appointment online with Dr. Chandan Krishna.
Accepting New Patients?
Yes, Dr. Chandan Krishna is accepting new patients at this office.
Phone
Address
13400 E Shea Boulevard, Scottsdale, Scottsdale, AZ 85259-5404
Office Details
Insurance Accepted
- Medicare
Bio
Dr. Chandan Krishna graduated from University Of Texas Medical Branch At Galveston in 2006.
Dr. Krishna has two offices in Texas and Arizona where he specializes in Neurosurgery.
Dr. Krishna works with five hundred and eighteen doctors including Dr. Craig Cohen and Dr. Tabitha Moe.
Specialty
-
Neurosurgery
As a neurosurgeon, Dr. Krishna is trained to perform highly technical surgeries to correct disorders of the central, autonomic or peripheral nervous systems. He may provide both invasive and minimally-invasive surgical treatment options, depending upon the patient's condition. Neurosurgeons may treat spinal disorders, traumatic brain injuries, tumors, Parkinson's disease, and more.
Education & Training
Hospital Affiliations
- Mayo Clinic Arizona
Languages Spoken
- English
Latest Neurosurgery News
-
Sleep, Don't Cram, Before Finals for Better GradesAmy Norton, HealthDay Reporter, Dec 10, 2018 at 12:00 PM
-
Catnip: The 'Why' Behind Cats' Favorite HighRobert Preidt, Dec 10, 2018 at 12:00 PM
-
FDA Warns of Rare Stroke Risk With MS DrugRobert Preidt, Dec 5, 2018 at 2:00 PM